Q0180 Dolasetron mesylate oral
Q-Codes
Also known as: Anzemet, dolasetron, 5-HT3 antagonist
Dolasetron mesylate oral formulation, a 5-HT3 receptor antagonist antiemetic used for prevention and treatment of nausea and vomiting.
Clinical Context
Used for chemotherapy-induced nausea/vomiting, postoperative nausea, and radiation-induced emesis. Oral formulation suitable for outpatient chemotherapy and post-op management.
RVU Breakdown
| Work RVU | 0.00 |
| Practice Expense RVU | 0.00 |
| Malpractice RVU | 0.00 |
| Total RVU | 0.00 |
Specialties
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.